Rachel Tansey, writer & researcher
Skip to content
High prices, poor access: What is Big Pharma fighting for in Brussels?
Human lives weighed against corporate profit
Big Pharma: un risque sanitaire? Radiopanik (FR)
Cooking the planet: Big Energy’s year of privileged access to Europe’s climate commissioners
The Transparency Facade: Pharma industry lobbying at the European Commission
Dirty hands on dirty deals: TTIP and COP21 shaped by same big business interests
Lobbying under the radar continues: MEP-industry forums still avoid scrutiny
(False) Solutions COP21 – a guide
Policy prescriptions: the firepower of the EU pharmaceutical lobby and implications for public health
Whose representatives? MEPs on the industry payroll
New and Improved?
Corporate Conquistadors: The Many Ways Multinationals Both Drive and Profit from Climate Destruction
The EU’s Revolving Door Problem: How Big Business Gains Privileged Access
A sustainable economy requires gender equality. Looking back at Day 3 of #Degrowth14